Cassiopea S.p.A. | Balance Sheet

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
7,251.20
1,010.00
52,317.40
36,079.10
20,592.80
5,194
Total Accounts Receivable
796.60
1,795.10
748.10
1,520.10
1,408.90
1,861.70
Other Current Assets
-
32.50
873.20
975.50
658.80
584.90
Total Current Assets
8,047.70
2,837.60
53,938.70
38,574.70
22,660.50
7,640.50
Net Property, Plant & Equipment
-
-
2.20
2.10
2.30
4.50
Total Investments and Advances
-
1,736.20
-
-
-
-
Intangible Assets
13.50
22.80
250.10
381.60
478.60
559
Other Assets
-
-
-
5,985.00
10,172.40
10,435.30
Total Assets
8,061.20
4,596.60
54,191.00
44,943.40
33,313.80
18,639.20
Accounts Payable
213.20
235.70
2,865.30
2,936.20
2,354.40
Income Tax Payable
2.50
1.20
14.10
12.90
30.40
Other Current Liabilities
0.00
-
7.60
26.80
90.10
Total Current Liabilities
215.70
236.90
2,887.00
2,975.90
2,474.90
Total Liabilities
215.70
236.90
2,887.00
2,975.90
2,474.90
Common Equity (Total)
7,845.50
4,359.80
51,304.00
41,967.50
30,838.90
Total Shareholders' Equity
7,845.50
4,359.80
51,304.00
41,967.50
30,838.90
Total Equity
7,845.50
4,359.80
51,304.00
41,967.50
30,838.90
Liabilities & Shareholders' Equity
8,061.20
4,596.60
54,191.00
44,943.40
33,313.80

About Cassiopea

View Profile
Address
Via Cristoforo Colombo, 1
Milan Milan 20020
Italy
Employees -
Website http://www.cassiopea.com
Updated 07/08/2019
Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It engages in developing and commercializing and medical dermatology products focusing on the topical treatment of acne, androgenic alopecia, and genital warts. The company products include Winlevi, Breezula, CB-06-02 and CB-06-01.